← 홈

프로그램 비교

타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일

현재 선택: 1개 · 임상 갱신 필요 1개

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

프로그램 선택

API CSV14행 · 1개 프로그램
OverviewToxicologyClinical

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
AntibodyCurated CorestaleApproved
Xolair (Xolair)
Roche / Novartis·Chronic Spontaneous Urticaria
2 trials
Overview
Program
Xolair
Overview
Company
Roche / Novartis
Overview
Modality
ANTIBODY
Overview
Target
Chronic Spontaneous Urticaria
Overview
Indication
Atopic Eczema; Atopic Dermatitis
Overview
Phase
APPROVED
Overview
Status
ACTIVE
Overview
Content status
Curated Core
Overview
Data Confidence
Data Confidence · High
Overview
Development Signal
Development Signal · Established
Overview
Approval status
Approved (flag incomplete)
Toxicology
Major finding
Safety of biologics for the treatment of asthma in children and adolescents: a systematic review.. Despite the clinical benefits, the administration of biologics in asthma is not without adverse effects. However, there is a lack of information on the safety profile, particularly in children. To provide a systematic review of the range of reported adverse events (AEs) of biologic treatments approve…
Clinical
Safety signal
Safety of biologics for the treatment of asthma in children and adolescents: a systematic review.. Despite the clinical benefits, the administration of biologics in asthma is not without adverse effects. However, there is a lack of information on the safety profile, particularly in children. To provide a systematic review of the range of reported adverse events (AEs) of biologic treatments approve…
Clinical
Program phase
APPROVED